Sa. Grover et al., LIFE EXPECTANCY FOLLOWING DIETARY MODIFICATION OR SMOKING CESSATION -ESTIMATING THE BENEFITS OF A PRUDENT LIFE-STYLE, Archives of internal medicine, 154(15), 1994, pp. 1697-1704
Objective: To evaluate the maximum benefits of dietary modification or
smoking cessation to the life expectancy of North American adults. De
sign: Using a computer model, we estimated the change in life expectan
cy for men and women following risk factor modification. We then estim
ated the total number of adults who would be targeted by national guid
elines and the total person-years of life that would be saved. Patient
s: Men and women aged 30 to 74 years who were free of coronary heart d
isease. Interventions: Smoking cessation or serum cholesterol-reducing
diets with 8% to 10% saturated fat and 240 to 300 mg of daily cholest
erol, respectively. Results: On average, dietary modification would re
duce serum cholesterol levels from 0.45 mmol/L (17.4 mg/dL) to 0.75 mm
ol/L (29.1 mg/dL) in men and 0.12 mmol/L (4.6 mg/dL) to 0.55 mmol/L (2
1.4 mg/dL) in women, thereby increasing life expectancy by 0.03 to 0.4
year and 0.01 to 0.16 year, respectively. Smoking cessation would inc
rease life expectancy from 2.59 to 4.43 years among men and from 2.6 t
o 3.68 years among women. Among adult Canadians, dietary modification
would save 373 000 to 683 000 person-years of life. The majority of th
ese benefits would occur among men who start dieting at ages 30 to 59
years. Smoking cessation would add more than 4 million person-years of
life to the Canadian population. The relative impact of either interv
ention among American adults would be similar to these Canadian estima
tes. Conclusions: Younger men, aged 30 to 59 years, might live slightl
y longer after dietary change, but among women and older men the avera
ge benefits would be negligible. The benefits of smoking cessation are
more uniform across age and sex and are substantially greater than th
ose predicted for dietary change.